Cargando…
The Impact of Carbamylation and Anemia on HbA(1c)’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease
OBJECTIVE: Glycated hemoglobin (HbA(1c)) can predict risk for microvascular complications in patients with diabetes. However, HbA(1c)’s reliability in chronic kidney disease (CKD) has been questioned, with concerns including competition from another posttranslational protein modification, carbamylat...
Autores principales: | Tang, Mengyao, Berg, Anders, Rhee, Eugene P., Allegretti, Andrew S., Nigwekar, Sagar, Karumanchi, S. Ananth, Lash, James P., Kalim, Sahir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797644/ https://www.ncbi.nlm.nih.gov/pubmed/36399777 http://dx.doi.org/10.2337/dc22-1399 |
Ejemplares similares
-
Protein carbamylation is associated with heart failure and mortality in diabetic patients with end stage renal disease
por: Drechsler, Christiane, et al.
Publicado: (2015) -
Relationship of HbA1c variability, absolute changes in HbA1c, and all-cause mortality in type 2 diabetes: a Danish population-based prospective observational study
por: Skriver, Mette V, et al.
Publicado: (2015) -
Empirically Establishing Blood Glucose Targets to Achieve HbA(1c) Goals
por: Wei, Nancy, et al.
Publicado: (2014) -
HbA(1c) and Coronary Heart Disease Risk Among Diabetic Patients
por: Zhao, Wenhui, et al.
Publicado: (2014) -
Sleep characteristics and HbA1c in patients with type 2 diabetes on glucose-lowering medication
por: Tan, Xiao, et al.
Publicado: (2020)